WASHINGTON, DC Feb 2, 2015 The president 's fiscal year 2016 budget sets an ambitious course for the national effort to prevent and treat life-threatening diseases such as cancer.
Following is a statement from John R. Seffrin, CEO of the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), about the Council on Foreign Relations report, “The Emerging Global Health Crisis: Noncommunicable Diseases in Low- and Middle-Income Countries,” which was issued today.
The American Cancer Society announced today that Rosemarie Rosie Henson, senior advisor to the assistant secretary for health at the U.S. Department of Health and Human Services (HHS), will join the Society as senior vice president for prevention and early detection, effective January 2015.
WASHINGTON, D.C. July 10, 2014 Following is a statement from John Seffrin, chief executive officer of the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), on the departure of Howard K.
Today marks both the first day of Breast Cancer Awareness Month and the opening of health insurance marketplaces in every state that enable people with breast cancer and other forms of cancer to enroll in health plans without fear that they will be denied coverage because of their health status or medical history.
WASHINGTON, D.C. August 15, 2013 A majority of states are not measuring up on legislative solutions that prevent and fight cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN).
WASHINGTON April 10, 2013 Families affected by cancer applaud President Obama for proposing an FY 2014 budget that would significantly reduce the impact of tobacco, a leading cause of cancer and preventable death, and commit to restoring the federal investment in medical research, the key to
WASHINGTON, D.C. August 9, 2012 A majority of states are not measuring up on legislative solutions that prevent and fight cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN).
WASHINGTON -- The Food and Drug Administration (FDA) announced today that it has revoked its approval of Avastin for metastatic breast cancer after concluding that the drug "has not been shown to be safe and effective for that use." The drug will remain an approved treatment for certain types of
Cancer patients and survivors today marked an historic milestone in the prevention and early detection of two of the deadliest cancers for women: the 10 millionth screening performed under the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), which provides access to lifesaving cancer screenings and treatment for millions of low-income, uninsured and underinsured women.